Our carefully researched speaker programmes are further enhanced by the opportunity for the delegates and speakers to discuss topics of interest in more detail during round table discussions. This means that the attendees not only benefit from the expertise of the high level speaker panel but also that of the other delegates.

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Mike Burden at

m.burden@oxfordglobal.co.uk

Below are some of the industry experts who have presented at our previous events or will be presenting at our upcoming events:

• Jonathan Knowles, President of Group Research, F. Hoffmann-La Roche
• Lee Babiss, Global Head of Research, F. Hoffmann-La Roche
• Rod MacKenzie, Senior Vice President, Head of Worldwide Research, Pfizer Inc
• Ismail Kola, Senior Vice President, Discovery Research and Early Clinical Research and Experimental Medicine, Schering Plough
• Lex Van der Ploeg, Senior Vice President, Integrative Medicine and Translational Science, Abraxis Bioscience
• Paul-Georg Germann, Senior Vice President, Head of Discovery to Proof of Concept Development Organisation, Nycomed
• Paul Clewlow, Senior Vice-President, Business Development, Argenta Discovery
• Stephan Fischer, Senior Vice President, Biologics Research and Strategy, Roche Pharma Research, Germany
• Melvyn Little, Chief Scientific Officer, Affimed Therapeutics AG
• Malcolm Weir, Chief Executive Officer, Heptares Therapeutics
• Ted Torphy, Chief Scientific Officer and Head, External Research & Early Development, Johnson & Johnson
• John Haurum, Chief Scientific Officer, Symphogen A/S
• Mikhail L. Gishizky, Chief Scientific Officer, Entelos
• Timothy Wells, Chief Scientific Officer, Medicines for Malaria
• Jutta Heim, Chief Scientific Officer, Basilea Pharmaceuticals
• Mike Collis, Chief Executive, The Physiological Society
• Bruno Flamion, Chair, CHMP Scientific Advice Working Party, EMEA
• Amrit Ray, Vice President, Global Pharmacovigilance & Epidemiology – Medical Safety, Bristol-Myers Squibb
• Christopher F. Reilly, Vice President Global Discovery Strategy and Performance, AstraZeneca
• Marc Laruelle, Vice President, Molecular Imaging, Clinical Pharmacology & Discovery Medicine, GlaxoSmithKline
• David Perry, Vice President, Global Clinical & Medical Affairs, Baxter
• Johann Proeve, Vice President, Global Head Data Management, Bayer-Schering Pharma
• Thomas Senderovitz, Vice President Global Exploratory Development, UCB Pharma SA
• Anthony Wood, Vice President and Head of Discovery Chemistry and Exploratory Medicinal Sciences, Pfizer.
• June Almenoff, Vice President, Safety Evaluation and Risk Management, GlaxoSmithKline
• Bahija Jallal, Vice President, Translational Sciences, MedImmune
• Peter Hoffmann, Vice President, New Technology Development, Genzyme
• Mark Bushfield, Vice President NCE Research, UCB Group
• Erin Duffy, Vice President, Structure-Based Drug Discovery, Rib-X Pharmaceuticals